Erivedge
Erivedge is a medicine authorised by Swissmedic under authorisation number 62497. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 May 2013 and the authorisation is valid without a time limit. ATC code L01XJ01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 62497 |
|---|---|
| Name | Erivedge |
| Full name | Erivedge, Kapseln |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XJ01 |
| First authorisation | 30 May 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Erivedge, Kapseln | A | 30 May 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | L01XJ01 | 07.16.4. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Erivedge authorised in Switzerland?
Yes. Erivedge is authorised by Swissmedic under authorisation number 62497, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Erivedge have?
Erivedge is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Erivedge?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.